Objectives Serial intralesional steroid injection (SILSI) is an emerging treatment for
idiopathic subglottic stenosis (ISGS), providing improvement in both subjective symptoms …

Objectives To characterize the impact of subglottic stenosis (SGS) on voice‐related quality of
life (V‐RQOL) and quantify the effect of treatment on voice outcomes. Study Design Case …

Objectives Serial intralesional steroid injection (SILSI) has been increasingly used to treat
idiopathic subglottic stenosis (iSGS). Prior studies have shown effectiveness, but not in all …

Objective: To describe treatment pathways and long-term outcomes in 64 patients with
idiopathic subglottic stenosis (iSGS), including the impact of serial intralesional steroid …

Objective: Office-based steroid injection has shown promise for idiopathic subglottic stenosis
(iSGS). It is important to understand safety and patient-lived experience. We report patient …

Objectives/Hypothesis The fibrotic/erythematous appearance of the subglottis in idiopathic
subglottic stenosis (iSGS) hints that it might respond to repeated intralesional steroid …

Objectives Idiopathic subglottic stenosis (ISGS) can have significant impacts on quality of life
(QOL), but it remains unclear how patients' subjective responses correlate with objective …

Objective: To determine the efficacy of office-based intralesional steroid injections (ILSI) as a
management therapy for adult subglottic stenosis (SGS). Data Sources: A systematic review …

Serial Intralesional Steroid Injection (SILSI) has been gaining popularity among patients and
physicians as a first-line treatment for idiopathic subglottic stenosis. Patients are followed by …

Purpose To assess the incidence and severity of 12 systemic side effects of serial
intralesional steroid injections (SILSI) in patients with idiopathic subglottic stenosis (iSGS) …